CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Samrat Pharmachem Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Samrat Pharmachem Ltd
701/702
Business Square, M. A. Road
Phone: +91 2226701050p:+91 2226701050 MUMBAI, 400058  India Ticker: 530125530125
Business Summary
Samrat Pharmachem Limited is an India-based manufacturer of iodine salts. The Company is engaged in manufacturing pharmaceutical ingredient products. The Company is research and development focused and has a multi-product portfolio with a manufacturing facility in Ankleshwar. It exports its products to geographics like United States, Europe, Africa, Asia, Middle East and others. It serves various industries, including agrochemical, animal feed, chemical, cosmetics, food, pharmaceutical, printing and textile. In agrochemical industry, its products include Iodine, methyl iodide, potassium iodide and sodium iodide. In animal feed industry, its products include calcium iodate, ethylenediamine di hydroiodide, potassium iodide and potassium iodate. In chemical industry, the Company's products include ammonium iodide, cadmium iodide, calcium iodate, iodine monochloride and methyl iodide. In pharmaceutical industry, its products include potassium iodide, periodic acid and povidone iodine.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
6/30/20243/31/2024Yes----

Industries
SIC Code Description
2834 Pharmaceutical preparations
8731 Commercial physical and biological research

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Executive Chairman of the Board, Managing Director Lalit D.Mehta 76 1/1/2016
Compliance Officer, Company Secretary Nishant K.Kankaria 5/22/2020 5/22/2020
Executive Director Megh R.Mehta 24 9/25/2017 9/25/2017
5 additional Officers and Directors records available in full report.

General Information
Number of Employees: 32 (As of 3/31/2024)
Outstanding Shares: 3,089,700 (As of 3/31/2024)
Stock Exchange: BOM
Fax Number: +91 2226701053


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Wednesday, November 20, 2024